We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$24B
AUM Growth
+$1.56B
(+6.9%)
Cap. Flow
-$931M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,059
New
128
Increased
454
Reduced
915
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$36.7M |
| 2 |
VICI Properties
VICI
|
+$32.5M |
| 3 |
Elevance Health
ELV
|
+$27.3M |
| 4 |
Arch Capital
ACGL
|
+$24.7M |
| 5 |
Kite Realty
KRG
|
+$24.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
Apple
AAPL
|
+$48.9M |
| 3 |
Synopsys
SNPS
|
+$44.7M |
| 4 |
Netflix
NFLX
|
+$40.2M |
| 5 |
Markel Group
MKL
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 12.06% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Atea Pharmaceuticals
AVIR
$379M
| $307K | ﹤0.01% |
100,700
| – | – |
|
1452
OptimizeRx
OPRX
$117M
| $307K | ﹤0.01% |
21,500
| – | – |
|
1453
OmniAb
OABI
$294M
| $306K | ﹤0.01% |
49,700
| – | – |
|
|
VZIO
1454
DELISTED
VIZIO Holding Corp.
VZIO
| $306K | ﹤0.01% |
39,800
-5,500
| -12% | -$34.4K |
|
|
CTLP
1455
DELISTED
Cantaloupe
CTLP
| $303K | ﹤0.01% |
41,000
| – | – |
|
1456
E.W. Scripps
SSP
$274M
| $300K | ﹤0.01% |
37,600
| – | – |
|
|
MZTI
1457
The Marzetti Company
MZTI
$2.94B
| $299K | ﹤0.01% |
1,800
-5,300
| -75% | -$891K |
|
|
SVC
1458
Service Properties Trust
SVC
$1.1B
| $298K | ﹤0.01% |
6,980
| – | – |
|
1459
TG Therapeutics
TGTX
$8.58B
| $298K | ﹤0.01% |
+17,500
| New | +$203K |
|
1460
LSI Industries
LYTS
$853M
| $297K | ﹤0.01% |
21,100
-15,800
| -43% | -$224K |
|
1461
Denali Therapeutics
DNLI
$3.67B
| $296K | ﹤0.01% |
13,800
| – | – |
|
1462
Ormat Technologies
ORA
$6.11B
| $295K | ﹤0.01% |
3,900
-700
| -15% | -$47.5K |
|
|
TBCH
1463
Turtle Beach Corp
TBCH
$239M
| $295K | ﹤0.01% |
27,000
+3,300
| +14% | +$32.3K |
|
1464
First Bank
FRBA
$451M
| $294K | ﹤0.01% |
20,000
-29,300
| -59% | -$363K |
|
1465
Patterson-UTI
PTEN
$3.87B
| $293K | ﹤0.01% |
27,200
-45,141
| -62% | -$549K |
|
|
UNIT
1466
Uniti Group
UNIT
$2.63B
| $291K | ﹤0.01% |
50,400
| – | – |
|
1467
DHI Group
DHX
$166M
| $289K | ﹤0.01% |
111,800
| – | – |
|
1468
Greenlight Captial
GLRE
$563M
| $288K | ﹤0.01% |
25,300
-18,900
| -43% | -$210K |
|
1469
Healthcare Services Group
HCSG
$1.56B
| $287K | ﹤0.01% |
27,700
| – | – |
|
1470
First Financial Bankshares
FFIN
$4.97B
| $284K | ﹤0.01% |
9,400
| – | – |
|
1471
Fox Factory Holding Corp
FOXF
$776M
| $283K | ﹤0.01% |
4,200
| – | – |
|
|
TWO
1472
Two Harbors Investment
TWO
$1.27B
| $282K | ﹤0.01% |
20,300
| – | – |
|
|
ALEX
1473
DELISTED
Alexander & Baldwin
ALEX
| $281K | ﹤0.01% |
14,800
-600
| -4% | -$10.1K |
|
1474
Hovnanian Enterprises
HOV
$785M
| $280K | ﹤0.01% |
1,800
-600
| -25% | -$60.4K |
|
1475
Revolution Medicines
RVMD
$40.2B
| $278K | ﹤0.01% |
9,700
+3,400
| +54% | +$81.7K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2023 Portfolio in Review
As of Q4 2023, STRS Ohio held 2,059 positions worth $24B, up 6.9% from $22.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
STRS Ohio withdrew a net $931M in Q4 2023, closing 153 positions and reducing 915 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $55.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, STRS Ohio opened a new position in Synovus worth $16.4M.
- STRS Ohio's largest Q4 2023 buy was Synovus: 436,000 shares worth $16.4M.
- STRS Ohio added most to Broadcom in Q4 2023, an estimated $36.7M increase.
- STRS Ohio's biggest Q4 2023 reduction was Apple, cutting an estimated $48.9M.
- STRS Ohio fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $55.4M.
- STRS Ohio's ten largest holdings make up 25% of its $24B portfolio in Q4 2023.
- STRS Ohio opened 128 new positions and closed 153 in Q4 2023.
- STRS Ohio's portfolio value rose 6.9% quarter-over-quarter to $24B.
Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.